Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Post by SamV21on Sep 20, 2022 5:59pm
121 Views
Post# 34974969

Read the side effects of YOUR WONDER DRUG Reduvo OR Marinol

Read the side effects of YOUR WONDER DRUG Reduvo OR Marinol Its a NARCOTIC  ! not a new soft drink , THE COMPANY that had made it before in Canada pulled it off the market THEMSELVES for safety and side effect concerns and didn't want to be sued .I am sure Guy knows this and even if it is approved he will sell it off to spend money on Qixleef and the other 10,000,000.00 bills that are coming due , but go ahead and average down, I thought you loaded the boat at .19 cents  a year ago because approval was anyday now and a sure thing  you and Guy can maybe share a cell after this goes drumsticks up. Scammer ! .Stop trying to suck people into this something happening soon message when there is nothing happening , READ MAY 2022 DISCUSSION AND ANALYSIS ! 
SEE YOU AT .04 CENTS SOON , WHEELS ARE COMING OFF THIS RIDE IN NOVEMBER WHEN TETRA HAS BILLS TO PAY.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities